Target Company Overview

Jianxin Pharmaceutical is a key player in the pharmaceutical sector, specializing in the research, production, and sales of various medical products, notably chemical drug formulations. The company boasts a diverse portfolio, capable of manufacturing large-volume injectables (including non-PVC soft bags, plastic bottles, and glass vials), lyophilized powder injections, small-volume injectables, tablets, and capsules. Jianxin Pharmaceutical has developed a total of 330 specifications across 202 product varieties, demonstrating its extensive capabilities in drug development.

The company has earned significant recognition for its innovative contributions, having received a Category One New Drug Certificate from the National Drug Administration for its independently developed Adefovir dipivoxil (both as an active ingredient and tablet form), as well as multiple awards, including the Shandong Province Science and Technology Progress First Prize. In recent years, from 2013 to 2015, Jianxin Pharmaceutical was named the